PetCaseFinder

Peer-reviewed veterinary case report

Metabolic changes in dogs with suspected toxic muscle disease

By Hunt, H et al.·Published in Toxicon : official journal of the International Society on Toxinology·2019·School of Veterinary Science·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Untargeted metabolic profiling of dogs with a suspected toxic mitochondrial myopathy using liquid chromatography-mass spectrometry.

Species:
dog

Plain-English summary

A group of dogs in New Zealand suspected of having 'Go Slow myopathy' (GSM) showed signs of muscle weakness after eating meat from wild pigs. This condition is thought to be linked to toxins from the environment, possibly from plants like white snakeroot. Researchers compared liver samples from healthy dogs and those with GSM and found significant differences in certain compounds, indicating possible mitochondrial dysfunction. While they couldn't pinpoint a specific toxin, the study suggests that the affected dogs had lower levels of certain fats and other substances in their livers.

People also search for: dog muscle weakness New Zealand · Go Slow myopathy symptoms · wild pig meat dog toxicity · mitochondrial dysfunction in dogs

Abstract

'Go Slow myopathy' (GSM) is a suspected toxic myopathy in dogs that primarily occurs in the North Island of New Zealand, and affected dogs usually have a history of consuming meat, offal or bones from wild pigs (including previously frozen and/or cooked meat). Previous epidemiological and pathological studies on GSM have demonstrated that changes in mitochondrial structure and function are most likely caused by an environmental toxin that dogs are exposed to through the ingestion of wild pig. The disease has clinical, histological and biochemical similarities to poisoning in people and animals from the plant Ageratina altissima (white snakeroot). Aqueous and lipid extracts were prepared from liver samples of 24 clinically normal dogs and 15 dogs with GSM for untargeted liquid chromatography-mass spectrometry. Group-wise comparisons of mass spectral data revealed 38 features that were significantly different (FDR<0.05) between normal dogs and those with GSM in aqueous extracts, and 316 significantly different features in lipid extracts. No definitive cause of the myopathy was identified, but alkaloids derived from several plant species were among the possible identities of features that were more abundant in liver samples from affected dogs compared to normal dogs. Mass spectral data also revealed that dogs with GSM have reduced hepatic phospholipid and sphingolipid concentrations relative to normal dogs. In addition, affected dogs had changes in the abundance of kynurenic acid, various dicarboxylic acids and N-acetylated branch chain amino acids, suggestive of mitochondrial dysfunction.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/31102596/